An epigenetic role of mitochondria in cancer

Y Liu, C Chen, X Wang, Y Sun, J Zhang, J Chen, Y Shi - Cells, 2022 - mdpi.com
Mitochondria are not only the main energy supplier but are also the cell metabolic center
regulating multiple key metaborates that play pivotal roles in epigenetics regulation. These …

Histone deacetylase inhibitors as anticancer drugs

T Eckschlager, J Plch, M Stiborova… - International journal of …, 2017 - mdpi.com
Carcinogenesis cannot be explained only by genetic alterations, but also involves
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …

Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

K Nepali, JP Liou - Journal of Biomedical Science, 2021 - Springer
Epigenetic drug discovery field has evidenced significant advancement in the recent times.
A plethora of small molecule inhibitors have progressed to clinical stage investigations and …

Microbiota-derived metabolite promotes HDAC3 activity in the gut

S Wu, S Hashimoto-Hill, V Woo, EM Eshleman, J Whitt… - Nature, 2020 - nature.com
The coevolution of mammalian hosts and their beneficial commensal microbes has led to
development of symbiotic host–microbiota relationships. Epigenetic machinery permits …

Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents

M Mottamal, S Zheng, TL Huang, G Wang - Molecules, 2015 - mdpi.com
Histone dacetylases (HDACs) are a group of enzymes that remove acetyl groups from
histones and regulate expression of tumor suppressor genes. They are implicated in many …

New and emerging HDAC inhibitors for cancer treatment

AC West, RW Johnstone - The Journal of clinical …, 2014 - Am Soc Clin Investig
Epigenetic enzymes are often dysregulated in human tumors through mutation, altered
expression, or inappropriate recruitment to certain loci. The identification of these enzymes …

Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host

W Timp, AP Feinberg - Nature Reviews Cancer, 2013 - nature.com
Although at the genetic level cancer is caused by diverse mutations, epigenetic
modifications are characteristic of all cancers, from apparently normal precursor tissue to …

[HTML][HTML] Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs

HJ Kim, SC Bae - American journal of translational research, 2011 - ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …

[PDF][PDF] HDAC and HDAC inhibitor: from cancer to cardiovascular diseases

S Yoon, GH Eom - Chonnam medical journal, 2016 - synapse.koreamed.org
Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail,
chromatin conformation, protein-DNA interaction, and even transcription. HDACs are also …

Anticancer activities of histone deacetylase inhibitors

JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …